advanced metastatic cancer and associated conditions without proving step therapy. A. A health benefit plan that provides coverage for advanced metastatic cancer and associated conditions may not require, before the health benefit plan provides coverage of a prescription drug approved by the United States Food and Drug Administration, that the enrollee:
1. Fails to successfully respond to a different drug; or 2. Proves a history of failure of a different drug. B. This section applies only to a drug, the use of which is:
1. Consistent with best practices for the treatment of advanced metastatic cancer or an associated condition;
2. Supported by peer-reviewed, evidence-based literature; and 3. Approved by the United States Food and Drug Administration.